Pharsight

Sarfe Pharms patents expiration

1. Soaanz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10154963 SARFE PHARMS Controlled-release formulations comprising Torsemide
Oct, 2033

(10 years from now)

Drugs and Companies using TORSEMIDE ingredient

Market Authorisation Date: 14 June, 2021

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

SOAANZ family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic